From the Mayo Clinic Cancer Center, Division of Medical Oncology, Rochester, MN.
Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL.
Pancreas. 2020 Aug;49(7):863-881. doi: 10.1097/MPA.0000000000001597.
This article is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management of pancreatic neuroendocrine tumors from July 19 to 20, 2018. The guidelines panel consisted of medical oncologists, pathologists, gastroenterologists, endocrinologists, and radiologists. The panel reviewed a series of questions regarding the medical management of patients with pancreatic neuroendocrine tumors as well as questions regarding surveillance after resection. The available literature was reviewed for each of the question and panel members voted on controversial topics, and the recommendations were included in a document circulated to all panel members for a final approval.
本文是 2018 年 7 月 19 日至 20 日北美神经内分泌肿瘤学会关于胰腺神经内分泌肿瘤的医学管理共识会议的成果。指南小组由肿瘤内科医生、病理学家、胃肠病学家、内分泌学家和放射科医生组成。小组审查了一系列关于胰腺神经内分泌肿瘤患者的医学管理问题，以及关于切除后监测的问题。针对每个问题，都对现有文献进行了回顾，小组成员对有争议的话题进行了投票，相关建议被纳入一份发给所有小组成员的文件，以供最终批准。
